| Literature DB >> 24106820 |
Alojzija Hočevar1, Boris Lestan, Snežna Sodin Šemrl, Katja Lakota, Nika Kojc, Nataša Potočnik, Matija Tomšič.
Abstract
Amyloid A (AA) (secondary) amyloidosis represents a severe complication of chronic inflammatory diseases. Since pathogenic mechanisms point to the central role of interleukin 6 (IL-6) in the process of amyloid AA generation, IL-6 blockade seems an attractive therapeutic option. We report a case of a patient with polyarteritis nodosa complicated by AA amyloidosis treated with tocilizumab.Entities:
Mesh：
Substances：
Year: 2013 PMID： 24106820 DOI： 10.3109/13506129.2013.838947
Source DB: PubMed Journal: Amyloid ISSN： 1350-6129 Impact factor: 7.141